A two-part, open-label, single-dose study designed to assess the mass balance recovery, metabolite profile and metabolite identification of [14C]-CORT125236 in healthy male subjects and to assess pharmacokinetics of CORT125236 tablet, including food effect in healthy subjects
A Phase I pharmacokinetic assessment of zavacorilant softgel capsule formulation, including dose proportionality and food effect in healthy subjects
An open-label, drug-drug interaction study designed to evaluate the potential effect of miricorilant on cytochrome P450 2C8, 2C9, 3A4, uridine-diphospho-glucuronosyltransferase 1A1 enzyme activity, and breast cancer resistance protein activity using probe substrates in healthy male and female subjects
100 项与 Corcept Therapeutics (United States) 相关的临床结果
0 项与 Corcept Therapeutics (United States) 相关的专利(医药)
100 项与 Corcept Therapeutics (United States) 相关的药物交易
100 项与 Corcept Therapeutics (United States) 相关的转化医学